| scholarly article | Q13442814 |
| P50 | author | Morinobu Endo | Q6912270 |
| Vincent Castranova | Q24747188 | ||
| Diane Schwegler-Berry | Q28036295 | ||
| Patti C. Zeidler-Erdely | Q28554085 | ||
| Aaron D. Erdely | Q70897226 | ||
| Petia P. Simeonova | Q84849179 | ||
| P2093 | author name string | Rebecca Salmen | |
| Shozo Koyama | |||
| Angie Liston | |||
| Tracy Hulderman | |||
| Yoong-Ahm Kim | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene | Q7187 |
| nanotechnology | Q11468 | ||
| condensed matter physics | Q214781 | ||
| bioengineering | Q580689 | ||
| biomarker | Q864574 | ||
| carbon nanotube | Q1778729 | ||
| respiratory disease | Q3286546 | ||
| respirable dust | Q19829512 | ||
| P5008 | on focus list of Wikimedia project | Wikimedia–NIOSH collaboration | Q104416361 |
| P304 | page(s) | 36-43 | |
| P577 | publication date | 2009-01-14 | |
| P1433 | published in | Nano Letters | Q787913 |
| P859 | sponsor | NIOSH Health Effects Laboratory Division | Q123344455 |
| P1476 | title | Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers | |
| P478 | volume | 9 |
| Q64081921 | A novel human 3D lung microtissue model for nanoparticle-induced cell-matrix alterations |
| Q38653410 | A review of toxicity studies of single-walled carbon nanotubes in laboratory animals |
| Q23918382 | A road map toward a globally harmonized approach for occupational health surveillance and epidemiology in nanomaterial workers |
| Q90752500 | Acute Phase Response as a Biological Mechanism-of-Action of (Nano)particle-Induced Cardiovascular Disease |
| Q47450519 | Acute in vitro and in vivo toxicity of a commercial grade boron nitride nanotube mixture |
| Q58068805 | Acute pulmonary and moderate cardiovascular responses of spontaneously hypertensive rats after exposure to single-wall carbon nanotubes |
| Q28387316 | Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation |
| Q38083288 | Are carbon nanotubes a natural solution? Applications in biology and medicine. |
| Q89591061 | Association of occupational exposures with ex vivo functional immune response in workers handling carbon nanotubes and nanofibers |
| Q55405475 | Association of pulmonary, cardiovascular, and hematologic metrics with carbon nanotube and nanofiber exposure among U.S. workers: a cross-sectional study. |
| Q53096026 | Binding of hydroxylated single-walled carbon nanotubes to two hemoproteins, hemoglobin and myoglobin. |
| Q96232052 | Bioactivity of circulatory factors after pulmonary exposure to mild- and stainless-steel welding fumes |
| Q64137344 | Biological monitoring of workers exposed to engineered nanomaterials |
| Q23913784 | Biomarkers of nanomaterial exposure and effect: current status |
| Q26344467 | Bridging the gap between exposure assessment and inhalation toxicology: some insights from the carbon nanotube experience |
| Q38824699 | Carbon Nanotubes in Biomedical Applications: Factors, Mechanisms, and Remedies of Toxicity |
| Q52716452 | Carbon nanotube and nanofiber exposure and sputum and blood biomarkers of early effect among U.S. workers. |
| Q23909542 | Carbon nanotube dosimetry: from workplace exposure assessment to inhalation toxicology |
| Q107001867 | Carbon nanotube exposure triggers a cerebral peptidomic response: barrier compromise, neuroinflammation and a hyperexcited state |
| Q28396192 | Carbon nanotubes as delivery systems for respiratory disease: do the dangers outweigh the potential benefits? |
| Q23916582 | Carbon nanotubes exposure risk assessment: from toxicology to epidemiologic studies (overview of the current problem) |
| Q37808226 | Carbon nanotubes in animal models: a systematic review on toxic potential |
| Q64056591 | Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials |
| Q39514008 | Cellular uptake, cytotoxicity, and ROS generation with silica/conducting polymer core/shell nanospheres |
| Q42702240 | Commercial single-walled carbon nanotubes effects in fibrinolysis of human umbilical vein endothelial cells. |
| Q64132335 | Current state of knowledge on the health effects of engineered nanomaterials in workers: a systematic review of human studies and epidemiological investigations |
| Q27332317 | Cytotoxic effect of poly-dispersed single walled carbon nanotubes on erythrocytes in vitro and in vivo |
| Q44550761 | Deriving TC50 values of nanoparticles from electrochemical monitoring of lactate dehydrogenase activity indirectly |
| Q58493174 | Differential effects of long and short carbon nanotubes on the gas-exchange region of the mouse lung |
| Q84186747 | Dispersion stabilization of silver nanoparticles in synthetic lung fluid studied under in situ conditions |
| Q23919200 | Effects of acute inhalation of aerosols generated during resistance spot welding with mild-steel on pulmonary, vascular and immune responses in rats |
| Q34743173 | Effects of lung exposure to carbon nanotubes on female fertility and pregnancy. A study in mice. |
| Q23917967 | Engineered carbonaceous nanomaterials manufacturers in the United States: workforce size, characteristics, and feasibility of epidemiologic studies |
| Q28387517 | Engineered nanomaterials: exposures, hazards, and risk prevention |
| Q23919501 | Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers |
| Q58235087 | Exosomes as Extrapulmonary Signaling Conveyors for Nanoparticle-Induced Systemic Immune Activation |
| Q28391912 | Expansion of cardiac ischemia/reperfusion injury after instillation of three forms of multi-walled carbon nanotubes |
| Q50022109 | Exposure assessments for a cross-sectional epidemiologic study of US carbon nanotube and nanofiber workers. |
| Q23920372 | Extrapulmonary transport of MWCNT following inhalation exposure |
| Q28950594 | Generation and characterization of aerosols released from sanding composite nanomaterials containing carbon nanotubes |
| Q48013570 | Health implications of engineered nanomaterials |
| Q28392504 | Helical carbon nanotubes enhance the early immune response and inhibit macrophage-mediated phagocytosis of Pseudomonas aeruginosa |
| Q58910342 | Human Biomonitoring of Engineered Nanoparticles: An Appraisal of Critical Issues and Potential Biomarkers |
| Q23909539 | Identification of systemic markers from a pulmonary carbon nanotube exposure |
| Q46938353 | Impact of diesel exhaust exposure on the liver of mice fed on omega-3 polyunsaturated fatty acids-deficient diet. |
| Q36808828 | Impact of experimental type 1 diabetes mellitus on systemic and coagulation vulnerability in mice acutely exposed to diesel exhaust particles |
| Q36887818 | In Vivo Toxicity Assessment of Occupational Components of the Carbon Nanotube Life Cycle To Provide Context to Potential Health Effects |
| Q39234619 | In vivo translocation and toxicity of multi-walled carbon nanotubes are regulated by microRNAs |
| Q112235301 | Indirect mediators of systemic health outcomes following nanoparticle inhalation exposure |
| Q88617065 | Inflammation in the pleural cavity following injection of multi-walled carbon nanotubes is dependent on their characteristics and the presence of IL-1 genes |
| Q23909537 | Inhalation exposure of gas-metal arc stainless steel welding fume increased atherosclerotic lesions in apolipoprotein E knockout mice |
| Q23913295 | Inhalation exposure to carbon nanotubes (CNT) and carbon nanofibers (CNF): methodology and dosimetry |
| Q44354982 | Inhibitory effects of multiwall carbon nanotubes with high iron impurity on viability and neuronal differentiation in cultured PC12 cells |
| Q28394494 | Innate Immune Responses to Nanoparticle Exposure in the Lung |
| Q23909992 | Integrated analysis of dysregulated ncRNA and mRNA expression profiles in humans exposed to carbon nanotubes |
| Q85649054 | Intratracheal exposure to multi-walled carbon nanotubes induces a nonalcoholic steatohepatitis-like phenotype in C57BL/6J mice |
| Q53591367 | Involvement of IL-1 genes in the cellular responses to carbon nanotube exposure. |
| Q23914732 | Lung toxicity and biodistribution of Cd/Se-ZnS quantum dots with different surface functional groups after pulmonary exposure in rats |
| Q23917668 | MMP-9-dependent serum-borne bioactivity caused by multiwalled carbon nanotube exposure induces vascular dysfunction via the CD36 scavenger receptor |
| Q54356472 | Maternal exposure to carbon black nanoparticle increases collagen type VIII expression in the kidney of offspring. |
| Q38063537 | Mechanisms of toxicity by carbon nanotubes |
| Q28389608 | Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? |
| Q51118438 | Molecular dynamics simulation of cytotoxicity of graphene nanosheets to blood-coagulation protein. |
| Q28389167 | Multi-walled carbon nanotube physicochemical properties predict pulmonary inflammation and genotoxicity |
| Q45266023 | Multiwall carbon nanotubes mediate macrophage activation and promote pulmonary fibrosis through TGF-β/Smad signaling pathway |
| Q39669666 | Multiwalled carbon nanotubes activate NF-κB and AP-1 signaling pathways to induce apoptosis in rat lung epithelial cells |
| Q33878315 | Nanocomposite synthesis by absorption of nanoparticles into macroporous hydrogels. Building a chemomechanical actuator driven by electromagnetic radiation. |
| Q87858435 | Nanomaterial exposure, toxicity, and impact on human health |
| Q77790215 | Nanoparticle exposure driven circulating bioactive peptidome causes systemic inflammation and vascular dysfunction |
| Q58235089 | Nanoparticle-Induced Exosomes Target Antigen-Presenting Cells to Initiate Th1-Type Immune Activation |
| Q37612053 | Nanoparticles and the blood coagulation system. Part II: safety concerns |
| Q38087984 | Nanoparticles and the cardiovascular system: a critical review |
| Q37739057 | Nanoparticles as a potential cause of pleural and interstitial lung disease |
| Q28394413 | Nanoparticles, human health hazard and regulation |
| Q23909944 | Nanotoxicology - a pathologist's perspective |
| Q57345630 | Nanotoxicology: Contemporary Issues and Future Directions |
| Q23915161 | National nanotechnology partnership to protect workers |
| Q51332818 | No toxicological effects on acute and repeated oral gavage doses of single-wall or multi-wall carbon nanotube in rats. |
| Q23923333 | Occupational nanosafety considerations for carbon nanotubes and carbon nanofibers |
| Q23909544 | Oxidative stress and reduced responsiveness of challenged circulating leukocytes following pulmonary instillation of metal-rich particulate matter in rats |
| Q38192502 | Perturbation of pulmonary immune functions by carbon nanotubes and susceptibility to microbial infection |
| Q38159140 | Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation. |
| Q104110040 | Physicochemical characterization and genotoxicity of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities |
| Q28386097 | Potential Occupational Risks Associated with Pulmonary Toxicity of Carbon Nanotubes |
| Q77791840 | Predicting occupational exposures to carbon nanotubes and nanofibers based on workplace determinants modeling |
| Q86511483 | Pulmonary DWCNT exposure causes sustained local and low-level systemic inflammatory changes in mice |
| Q51056191 | Pulmonary and atherogenic effects of multi-walled carbon nanotubes (MWCNT) in apolipoprotein-E-deficient mice. |
| Q108918747 | Pulmonary delivery of the broad-spectrum matrix metalloproteinase inhibitor marimastat diminishes multiwalled carbon nanotube-induced circulating bioactivity without reducing pulmonary inflammation |
| Q26322761 | Pulmonary effects of carbon nanomaterials |
| Q40074494 | Pulmonary exposure to particles from diesel exhaust, urban dust or single-walled carbon nanotubes and oxidatively damaged DNA and vascular function in apoE(-/-) mice |
| Q39438953 | Quantum dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung |
| Q23909536 | Relationship between pulmonary and systemic markers of exposure to multiple types of welding particulate matter |
| Q27023304 | Right or left: the role of nanoparticles in pulmonary diseases |
| Q39326450 | Risk management strategy to increase the safety of workers in the nanomaterials industry |
| Q38248454 | Role of oxidative stress in carbon nanotube-generated health effects |
| Q112235982 | Serum peptidome: diagnostic window into pathogenic processes following occupational exposure to carbon nanomaterials |
| Q28950553 | Serum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood-brain barrier impairment |
| Q42708592 | Silver nanoparticles induce anti-proliferative effects on airway smooth muscle cells. Role of nitric oxide and muscarinic receptor signaling pathway. |
| Q45067933 | Sparse Supervised Classification Methods Predict and Characterize Nanomaterial Exposures: Independent Markers of MWCNT Exposures |
| Q42702909 | Subchronic toxicity and cardiovascular responses in spontaneously hypertensive rats after exposure to multiwalled carbon nanotubes by intratracheal instillation. |
| Q83369471 | Teratogenicity of multi-wall carbon nanotube (MWCNT) in ICR mice |
| Q37761685 | Testing metal-oxide nanomaterials for human safety |
| Q33565106 | The acute pulmonary and thrombotic effects of cerium oxide nanoparticles after intratracheal instillation in mice |
| Q37877482 | Toxicity evaluations of various carbon nanomaterials. |
| Q89537004 | Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers |
| Q84410854 | Treatment of acute thromboembolism in mice using heparin-conjugated carbon nanocapsules |
| Q23909543 | Type I interferon and pattern recognition receptor signaling following particulate matter inhalation |
| Q23919497 | Update on carbon nanotube toxicity |
Search more.